LSL. V. Selivanova

L. V. Selivanova

*This is an algorithmically generated author record based on publicly available information.

L. V. Selivanova has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pharmacogenetic approach to prescribing medications in cardiac surgery patients at high risk of complications

    by L. V. Selivanova, M. V. Lukina, V. S. Yudin, D. A. Petrenko, K. A. Vilizhinskaya, Yu. S. Gilevskaya, S. O. Popov, I. V. Sychev, D. E. Rozhkov, K. B. Mirzaev, et al.

    Introduction. Cardiac surgery patients are at high pharmacological risk due to comorbidities, polypharmacy, and cardiopulmonary bypass. Search methods. A literature search was conducted in PubMed/MEDLINE, Web of Science, Scopus, and eLibrary.ru (2015-2025) using keywords: “pharmacogenetics AND cardiac surgery”, “warfarin pharmacogenetics”, “clopidogrel CYP2C19”, “SLCO1B1 statin myopathy”, “drug-gene interactions”. In total, 42 sources were selected and analyzed. Inclusion criteria: original studies, meta-analyses, systematic reviews, and clinical guidelines in English or Russian. Exclusion criteria: single case reports, experimental studies, conference abstracts without full text. Results. VKORC1 and CYP2C9 polymorphisms account for 50–60 % of warfarin dose variability; genotyping reduces bleeding risk and accelerates time to therapeutic INR. Loss-of-function CYP2C19 alleles impair clopidogrel activation, increasing ischemic event risk. The SLCO1B1 variant is associated with higher risk of statin-induced myopathy. In the Russian population, the frequency of clinically relevant alleles is comparable to European populations. Drug — gene and drugdrug-gene interaction concepts may potentiate adverse outcomes. Implementation of pharmacogenetic testing is limited by organizational, financial, and educational barriers. Conclusion. For cardiac surgery patients, a multiparametric algorithm incorporating multilocus genotyping (CYP2C9, VKORC1, CYP2C19, SLCO1B1, ABCG2), clinical factor assessment, and drug interaction evaluation is the most promising strategy.

  • Open Access

    Efficacy and safety of human albumin solutions in adult patients undergoing cardiac surgery

    by D. A. Reznik, D. A. Petrenko, L. V. Selivanova, M. A. Balalaeva, R. D. Komnov, A. A. Eremenko, A. A. Anderzhanova, Yu. A. Melyoshkina, M. I. Tsarev, M. V. Lukina, et al.

    Introduction . Human albumin (HA) solution is commonly used in cardiac surgery for hypovolemia correction, hemodynamic stabilization, and as a component of perfusion media. Despite its widespread use, the efficacy and safety of HA in cardiac surgery patients remain debated. Existing evidence is conflicting: some studies suggest potential benefits for hemodynamic control and renal function, while others show no significant advantage over crystalloids or synthetic colloids regarding key outcomes such as mortality and complication rates. The lack of unified clinical guidelines or algorithms for HA administration in the perioperative period, coupled with its high cost, underscores the need for a systematic review of current evidence to define clear and justified indications for its use in this specific patient population. The objective was to review the literature on the effectiveness and safety of using HA solutions in adult cardiac surgery patients Materials and methods . Based on the analysis of literature in the PubMed, Cochrane Library, eLibrary, Google Scholar databases, publications were selected with search restrictions on the following parameters: «people», «adults», «efficacy», «safety», «replenishment of CBV», «hypoalbuminemia », «intensive care», «surgical intervention», «cardiac surgery», «mortality», «survival». Results . According to the literature analysis, the use of HA solutions in cardiac surgery patients in the situation of hypovolemia correction and hemodynamic stabilization is justified. Preference should be given to isooncotic HA solution (4–5%). The administration of HA solution does not affect the frequency of postoperative complications, mortality, length of stay in the intensive care unit and hospital. Conclusions . The use of HA solutions in cardiac surgery patients requires an individual approach, assessment of the clinical condition and potential benefits of its physiological effects in certain clinical scenarios, however, additional randomized clinical studies comparing albumin 5% and albumin 20% in this population are needed for final conclusions.

  • Open Access

    Clinical case of effective treatment of invasive mycosis caused by polyresistant strain of Candida auris

    by L. V. Selivanova, M. A. Balalaeva, O. V. Dymova, E. V. Chernova, M. V. Lukina, A. A. Krucenko, D. A. Petrenko, S. S. Dmitrieva, A. A. Eremenko

    The objective was to demonstrate a clinical case of effective treatment of a patient with invasive mycosis caused by Candida auris with drug resistance to antifungal drugs by a combination of micafungin and amphotericin B lipid complex.Materials and methods. International databases such as MEDLINE, EMBASE, Web of Science and Scopus until 2023 were used for the analysis.Results. We have demonstrated the effective case of treatment of invasive candidiasis caused by the polyresistent pathogen Candida auris with the combination of micafungin and amphotericin B in the patient who underwent mitral valve replacement, which was complicated by acute aortic dissection, acute thrombosis of the superior mesenteric artery, septic shock and a number of other nosocomial infections.Conclusion. Due to the high resistance of Candida auris to all antifungal drugs currently existing in the world, the combination of several antifungal drugs is an advantage over monotherapy. However, given the lack of approved standards and guidelines for the treatment of patients with this infection, and insufficient clinical experience in the management of such patients, further search for effective treatment regimens for infections caused by Candida auris and the development of new antifungal agents that can overcome the resistance of this pathogen are necessary.

  • Open Access

    A Clinical Case of Effective Treatment of Pneumonia Caused by Polyresistant Strains with the Use of Inhalation Colistimethate Sodium

    by M. A. Balalaeva, L. V. Selivanova, O. V. Dymova, D. V. Bazarov, E. V. Chernova, M. V. Lukina, A. A. Eremenko

    Клинический случай эффективного лечения пневмонии, вызванной полирезистентными штаммами, с использованием ингаляционного колистиметата натрия